Cocrystal Pharma (COCP) Competitors

CASI Pharmaceuticals (NASDAQ:CASI) and Cocrystal Pharma (NASDAQ:COCP) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership.

Does the MarketBeat Community prefer CASI or COCP?

CASI Pharmaceuticals received 177 more outperform votes than Cocrystal Pharma when rated by MarketBeat users. However, 76.67% of users gave Cocrystal Pharma an outperform vote while only 50.25% of users gave CASI Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
CASI Pharmaceuticals	Outperform Votes 200 50.25%	Underperform Votes 198 49.75%
Cocrystal Pharma	Outperform Votes 23 76.67%	Underperform Votes 7 23.33%

Is CASI or COCP more profitable?

Cocrystal Pharma has a net margin of 0.00% compared to CASI Pharmaceuticals' net margin of -143.18%. Cocrystal Pharma's return on equity of -94.62% beat CASI Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CASI Pharmaceuticals	-143.18%	-174.89%	-46.11%
Cocrystal Pharma	N/A	-94.62%	-78.24%

Do analysts rate CASI or COCP?

CASI Pharmaceuticals currently has a consensus price target of $6.00, indicating a potential upside of 14.94%. Cocrystal Pharma has a consensus price target of $7.00, indicating a potential upside of 239.81%. Given Cocrystal Pharma's higher possible upside, analysts clearly believe Cocrystal Pharma is more favorable than CASI Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CASI Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Cocrystal Pharma	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media favor CASI or COCP?

In the previous week, CASI Pharmaceuticals and CASI Pharmaceuticals both had 4 articles in the media. Cocrystal Pharma's average media sentiment score of 0.76 beat CASI Pharmaceuticals' score of 0.50 indicating that Cocrystal Pharma is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CASI Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cocrystal Pharma	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, CASI or COCP?

CASI Pharmaceuticals has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, Cocrystal Pharma has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500.

Do insiders & institutionals have more ownership in CASI or COCP?

22.2% of CASI Pharmaceuticals shares are owned by institutional investors. Comparatively, 6.7% of Cocrystal Pharma shares are owned by institutional investors. 21.2% of CASI Pharmaceuticals shares are owned by company insiders. Comparatively, 25.6% of Cocrystal Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Which has stronger valuation & earnings, CASI or COCP?

Cocrystal Pharma has lower revenue, but higher earnings than CASI Pharmaceuticals. CASI Pharmaceuticals is trading at a lower price-to-earnings ratio than Cocrystal Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CASI Pharmaceuticals	$22.06M	3.66	-$26.94M	-$2.23	-2.34
Cocrystal Pharma	N/A	N/A	-$17.98M	-$1.85	-1.11

Summary

Cocrystal Pharma beats CASI Pharmaceuticals on 10 of the 14 factors compared between the two stocks.